Cargando…
Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
Autores principales: | Aghamohammadi, Mehdi, Alizargar, Javad, Hsieh, Nan-Chen, Wu, Shu-Fang Vivienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Formosan Medical Association. Published by Elsevier Taiwan LLC.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211643/ https://www.ncbi.nlm.nih.gov/pubmed/32402522 http://dx.doi.org/10.1016/j.jfma.2020.05.005 |
Ejemplares similares
-
Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis
por: Alizargar, Javad, et al.
Publicado: (2020) -
Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020) -
The novel coronavirus (COVID-19) and the risk of Kawasaki disease in children
por: Alizargar, Javad
Publicado: (2020) -
Using the Cardio-Ankle Vascular Index (CAVI) or the Mathematical Correction Form (CAVI(0)) in Clinical Practice
por: Alizargar, Javad, et al.
Publicado: (2020) -
Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
por: Alizargar, Javad, et al.
Publicado: (2020)